Shandong Buchang Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002FV6
CNY
16.08
-0.08 (-0.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
2,579.01
3,406.43
2,804.75
2,878.89
2,784.95
2,491.39
3,082.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,579.01
3,406.43
2,804.75
2,878.89
2,784.95
2,491.39
3,082.73
Raw Material Cost
945.27
1,246.26
1,099.66
1,104.67
1,101.58
855.27
1,393.85
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
28.72
30.11
28.72
31.13
28.74
34.82
32.21
Selling and Distribution Expenses
1,133.27
1,677.31
1,306.28
1,309.26
1,221.38
1,318.52
1,396.20
Other Expenses
1.41
5.47
3.91
0.49
1.33
12.70
2.26
Total Expenditure (Excl Depreciation)
2,121.37
3,008.40
2,473.72
2,449.93
2,365.06
2,335.61
2,844.84
Operating Profit (PBDIT) excl Other Income
457.59999999999997
398
331
429
419.90000000000003
155.8
237.89999999999998
Other Income
3.11
16.60
10.64
9.15
25.24
-11.60
-56.48
Operating Profit (PBDIT)
422.89
162.65
408.08
540.86
544.68
-688.34
279.73
Interest
28.72
30.11
28.72
31.13
28.74
34.82
32.21
Exceptional Items
-2.40
-512.50
10.33
1.30
2.08
0.63
2.17
Gross Profit (PBDT)
1,633.75
2,160.17
1,705.08
1,774.22
1,683.36
1,636.12
1,688.88
Depreciation
0.00
97.87
118.83
141.97
141.97
153.13
153.13
Profit Before Tax
391.77
-477.84
270.86
369.06
376.05
-875.66
96.56
Tax
79.48
112.21
70.09
73.12
86.24
53.13
61.13
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
320.41
-507.54
240.62
320.44
307.26
-866.66
81.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
320.41
-507.54
240.62
320.44
307.26
-866.66
81.45
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-17.31
-91.29
-39.72
-20.10
-17.37
-53.61
-44.71
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
303.10
-598.83
200.90
300.34
289.89
-920.27
36.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
10,220.64
10,011.88
10,572.99
10,744.01
10,475.03
10,216.46
11,161.12
Earnings per share (EPS)
0.3
-0.48
0.23
0.3
0.29
-0.82
0.08
Diluted Earnings per share
0.3
-0.48
0.23
0.3
0.29
-0.82
0.08
Operating Profit Margin (Excl OI)
16.28%
1.41%
9.93%
13.54%
13.55%
-33.31%
5.94%
Gross Profit Margin
15.19%
-11.15%
13.89%
17.75%
18.6%
-29.0%
8.1%
PAT Margin
12.42%
-14.9%
8.58%
11.13%
11.03%
-34.79%
2.64%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -24.29% vs 21.45% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 150.62% vs -398.06% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 187.53% vs -63.26% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -4.65% vs 4.88% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Shandong Buchang Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,579.01
0
2,579.01
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,579.01
0
2,579.01
Raw Material Cost
945.27
0
945.27
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
28.72
0
28.72
Selling and Distribution Expenses
1,133.27
0
1,133.27
Other Expenses
1.41
0.00
1.41
Total Expenditure (Excl Depreciation)
2,121.37
0
2,121.37
Operating Profit (PBDIT) excl Other Income
457.64
0.00
457.64
Other Income
3.11
0
3.11
Operating Profit (PBDIT)
422.89
0
422.89
Interest
28.72
0
28.72
Exceptional Items
-2.40
0
-2.40
Gross Profit (PBDT)
1,633.75
0
1,633.75
Depreciation
0.00
0
0.00
Profit Before Tax
391.77
0
391.77
Tax
79.48
0
79.48
Provisions and contingencies
0
0
0.00
Profit After Tax
320.41
0
320.41
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
320.41
0
320.41
Share in Profit of Associates
0
0
0.00
Minority Interest
-17.31
0
-17.31
Other related items
0.00
0.00
0.00
Consolidated Net Profit
303.10
0
303.10
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
10,220.64
0
10,220.64
Earnings per share (EPS)
0.30
0
0.30
Diluted Earnings per share
0.30
0
0.30
Operating Profit Margin (Excl OI)
16.28%
0%
0.00
16.28%
Gross Profit Margin
15.19%
0%
0.00
15.19%
PAT Margin
12.42%
0%
0.00
12.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 257.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -24.29% vs 21.45% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -7.39% vs 5.46% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 30.31 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 150.62% vs -398.06% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 4.55% vs 230.56% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.98 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 187.53% vs -63.26% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -19.18% vs 38.84% in Mar 2025

Quarterly - Interest
Interest 2.87 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -4.65% vs 4.88% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 0.00% vs -2.38% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.28%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025